Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	May. 31, 2015	May. 31, 2014
Cash flows from operating activities:
Net loss	$ (17,372)	$ (37,187)
Adjustments to reconcile net income to net cash used in operating activities:
Equity in income of unconsolidated joint ventures	(1,607)	(1,900)
Amortization of discounts and issuance costs	3,914	3,360
Depreciation and amortization	1,646	1,026
Deferred income taxes	5,700	0
Stock-based compensation	7,428	3,725
Noncash Project Abandonment Costs	984	790
Change in assets and liabilities:
Receivables	(17,999)	(17,101)
Inventories	(116,664)	(579,173)
Accounts payable, accrued expenses and other liabilities	(34,048)	2,474
Other, net	(2,626)	(4,917)
Net cash used in operating activities	(135,900)	(554,529)
Cash flows from investing activities:
Return of investments in (contributions to) unconsolidated joint ventures	(13,244)	(16,242)
Proceeds from sale of investment in unconsolidated joint venture	0	10,110
Purchases of property and equipment, net	(1,590)	(3,012)
Net cash provided by (used in) investing activities	(14,834)	(9,144)
Cash flows from financing activities:
Change in restricted cash	22	(2,331)
Proceeds from issuance of debt	250,000	400,000
Payment of debt issuance costs	(3,337)	(5,448)
Payments on mortgages and land contracts due to land sellers and other loans	(7,757)	(6,476)
Proceeds from Issuance or Sale of Equity	0	137,045
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options	25	64
Payments of cash dividends	(4,599)	(4,388)
Stock repurchases	(300)	(46)
Net cash provided by (used in) financing activities	234,054	518,420
Net increase (decrease) in cash and cash equivalents	83,320	(45,253)
Cash and cash equivalents at beginning of period	358,768	532,523
Cash and cash equivalents at end of period	$ 442,088	$ 487,270